February 8, 2019

BONESUPPORT – Publication of pre-clinical study highlighting unique bone remodeling qualities of CERAMENT® in large bone defects

Lund, Sweden, 08.00 CET, 08 February 2019 – BONESUPPORT, anemerging leader in orthobiologics for the management of bone voids, today announces the publication of ground-breaki...
Read more
February 4, 2019

GenSight Biologics reports topline results at Week 48 of the RESCUE Phase III clinical trial of GS010 in subjects within six months of visual loss onset due to Leber Hereditary Optic Neuropathy (LHON)

Mean best-corrected visual acuity (BCVA) among GS010-treated eyes and sham-treated eyes evolved with similar trajectories, worsening to a low point, or nadir, before beginning ...
Read more
February 1, 2019

BONESUPPORTTM and Lund University to present at Orthopaedic Research Society (ORS) 2019 Annual Meeting

Lund, Sweden, 08.00 CET, 1 February 2019 – BONESUPPORTTM, anemerging leader in orthobiologics for the management of bone voids, today announces two oral presentations, and t...
Read more
January 30, 2019

Q4 incl. Full Year Report 2018

2018 was a pivotal year for Orexo Q4 2018 highlights Total net revenues of SEK 227.1 million (191.0), up 18.9 percent from Q4 previous year Zubsolv® US net revenue ...
Read more
January 29, 2019

Modus Therapeutics strengthens Board with two key appointments

STOCKHOLM, SWEDEN – 29 January 2019: Modus Therapeutics AB, a company developing innovative treatments in high unmet medical need disease areas with a focus on sickle cell diseas...
Read more
January 29, 2019

Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress™ in Vienna, Austria

GAITHERSBURG, Md., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced results of its recently complet...
Read more
January 25, 2019

Nordic Nanovector – Private placement successfully completed

Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia Oslo, Norway, 25 January 2019 Refe...
Read more
January 24, 2019

Nordic Nanovector ASA (OSE: NANO) nomination committee proposes new Chairman

Oslo, Norway, 24 January 2019 In the nomination committee's recommendation to the Company's annual general meeting in 2018, it was informed that the chairman of the bo...
Read more
January 24, 2019

Oncopeptides has completed a directed share issue of approximately SEK 546 million

January 24, 2019 - Regulatory press release NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRA...
Read more
January 17, 2019

Targovax granted European Patent for mutant-RAS neoantigen platform lead products

Extends IP protection of TG01 and TG02 until 06.05.2034 Oslo, 17 January 2019: Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage company focuse...
Read more